|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.61 CNY | -2.26% |
|
-8.18% | -25.30% |
| 05-07 | Shuangcheng Pharma Gets FDA Nod to Market Acromegaly Drug in US | MT |
| 04-29 | Hainan Shuangcheng Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Hainan Shuangcheng Pharmaceuticals Co., Ltd. elected Bai Jing as non-independent director of the company, at its first extraordinary general meeting of 2022 held on 26 January 2022.
| 1st Jan change | Capi. | |
|---|---|---|
| -25.30% | 331M | |
| +21.59% | 44.15B | |
| +23.03% | 23.02B | |
| +18.22% | 15.33B | |
| +12.26% | 13.74B | |
| +52.55% | 12.16B | |
| -10.02% | 6.84B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.92% | 5.66B |
HAINAN SHUANGCHENG PHARMACEUTICALS CO., LTD. 
